Thomas Wilder

Mr. Thomas C.
Wilder is a Chief Executive Officer at VS3 Medical, Inc., an Advisor at Vensana Capital Management LLC, an Independent Director at Penumbra, Inc. and an Independent Director at Neuros Medical, Inc. He is on the Board of Directors at Penumbra, Inc. and Neuros Medical, Inc. Mr. Wilder was previously employed as a Senior Advisor by CBC Group (Singapore) Pte.
Ltd., an Independent Director by Endologix LLC, a President, Chief Executive Officer & Director by Sequent Medical, Inc., a President & Chief Executive Officer by PhotoThera, Inc., a President & Chief Executive Officer by Micro Therapeutics, Inc., a VP & GM-Endovascular Stent Grafts Division by Medtronic, Inc., a President by ev3, Inc., and a Vice President-Finance & Information Technology by Medtronic Vascular, Inc. He also served on the board at Benvenue Medical, Inc. He received his undergraduate degree from Stanford University and an MBA from Kellogg School of Management.